These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9663703)

  • 1. Fibrinolytic agents inhibit platelet adhesion onto collagen type I-coated surfaces at high blood flow conditions.
    Huang TC; Graham DA; Nelson LD; Alevriadou BR
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):213-26. PubMed ID: 9663703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shear-dependent functions of the interaction between soluble von Willebrand factor and platelet glycoprotein Ib in mural thrombus formation on a collagen surface.
    Sugimoto M; Tsuji S; Kuwahara M; Matsui H; Miyata S; Fujimura Y; Yoshioka A
    Int J Hematol; 1999 Jan; 69(1):48-53. PubMed ID: 10641443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
    Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
    Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.
    Sixma JJ; Ijsseldijk MJ; Hindriks G; van Zanten GH; Gorecki M; Panet A; Garfinkel LI; de Groot PG
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):64-71. PubMed ID: 8548428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC; Zaleski A; Nichols WL; Olson JD
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib.
    Fressinaud E; Baruch D; Girma JP; Sakariassen KS; Baumgartner HR; Meyer D
    J Lab Clin Med; 1988 Jul; 112(1):58-67. PubMed ID: 2455762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction.
    Wu YP; Vink T; Schiphorst M; van Zanten GH; IJsseldijk MJ; de Groot PG; Sixma JJ
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1661-7. PubMed ID: 10845886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow.
    Turner NA; Moake JL; McIntire LV
    Blood; 2001 Dec; 98(12):3340-5. PubMed ID: 11719372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependence of plasmin-mediated degradation of platelet adhesive receptors on temperature and Ca2+.
    Winters KJ; Eisenberg PR; Jaffe AS; Santoro SA
    Blood; 1990 Oct; 76(8):1546-57. PubMed ID: 2169924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions.
    Dong JF; Cruz MA; Aboulfatova K; Martin C; Choi H; Bergeron AL; Martini SR; Kroll MH; Kent TA
    Thromb Haemost; 2008 Mar; 99(3):586-93. PubMed ID: 18327408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
    Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
    Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions.
    Ross JM; McIntire LV; Moake JL; Rand JH
    Blood; 1995 Apr; 85(7):1826-35. PubMed ID: 7703489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor.
    Dardik R; Ruggeri ZM; Savion N; Gitel S; Martinowitz U; Chu V; Varon D
    Thromb Haemost; 1993 Sep; 70(3):522-6. PubMed ID: 8259558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor.
    Shenkman B; Savion N; Dardik R; Tamarin I; Varon D
    Thromb Res; 2000 Aug; 99(4):353-61. PubMed ID: 10963786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
    De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.